Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)
China · Delayed Price · Currency is CNY 6.80
+0.05 (0.74%)
Aug 4, 2026, 3:04 PM CST
Xiangxue Pharmaceutical Market Cap
Xiangxue Pharmaceutical has a market cap or net worth of 4.5 billion as of August 4, 2026. Its market cap has decreased by -15.21% in one year.
Market Cap
4.50B
Enterprise Value
6.18B
Revenue
1.53B
Ranking
n/a
PE Ratio
n/a
Stock Price
6.80
ChartMarket Cap Chart
Since December 15, 2010, Xiangxue Pharmaceutical's market cap has decreased from 4.81B to 4.50B, a decrease of -6.50%. That is a compound annual growth rate of -0.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 4.50B | -25.27% |
| Dec 31, 2025 | 6.02B | -6.86% |
| Dec 31, 2024 | 6.46B | 89.71% |
| Dec 29, 2023 | 3.41B | -14.02% |
| Dec 30, 2022 | 3.96B | -24.79% |
| Dec 31, 2021 | 5.27B | -9.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novogene | 5.15B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.80B |
| Beijing Konruns Pharmaceutical | 4.69B |
| Suzhou Fengbei Biotech Stock | 4.67B |
| R&G PharmaStudies | 4.53B |
| Shenzhen Weiguang Biological Products | 4.52B |
| ChemPartner PharmaTech | 4.46B |
| PharmaResources (Shanghai) | 4.37B |